Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR

Vaccine

Volumn 22, Issue 19, 2004, Pages 2457-2469

  Viret, Jean François ^a   Dietrich, Guido ^a   Favre, Didier ^a  

^a Berna Biotech AG   (Switzerland)

Author keywords

Cholera; Environmental safety; Gene transfer; Genetic stability; GMO based; Risk assessment; Vaccine; Vibrio cholerae

Indexed keywords

BACTERIAL VACCINE; CHOLERA VACCINE; DNA VACCINE; LIVE VACCINE;

BIOSAFETY; CHOLERA; CONFERENCE PAPER; DNA SEQUENCE; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL RELEASE; GENE TRANSFER; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTHERN BLOTTING; VIBRIO CHOLERAE;

ADMINISTRATION, ORAL; CHOLERA; CHOLERA VACCINES; GENE TRANSFER TECHNIQUES; SAFETY; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIBRIO CHOLERAE;

EID: 2942588684     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.12.033     Document Type: Conference Paper

References (96)

1. Levine M.M. Can needle-free administration of vaccines become the norm in global immunization? Nat Med. 9:2003;99-103
2. Neutra M.R., Frey A., Kraehenbuhl J.-P. Epithelial cells: gateways for mucosal infection and imminisation. Cell. 86:1996;345-348
3. Kraehenbuhl J.P., Neutra M.R. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol. 16:2000;301-332
4. Moldoveanu Z., Russell M.W., Wu H.Y., Huang W.Q., Compans W., Mestecky J. Compartmentalisation within the common mucosal immune system. Adv Exp Med Biol. 371:1995;97-101
5. Sabin A.B., Boulger L.R. History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand. 1:1973;115-118
6. Levine M.M., Ferreccio C., Cryz S., Ortiz E. Comparison of enteric coated-capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet. 336:1990;891-894
7. Levine M.M., Kaper J.B. Live oral vaccines against cholera: an update. Vaccine. 11:1993;207-212
8. Sanchez J.L., Vasquez B., Begue R.E., et al. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet. 344:1994;1273-1276
9. Lagranderie M., Chavarot P., Balazuc A.M., Marchal G. Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice. Vaccine. 18:2000;1186-1195
10. Murphy T.V., Gargiullo P.M., Massoudi M.S., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 344:2001;564-572
11. Kaufmann SHE. Immunity to intracellular bacteria. In: Paul WE, editor. Fundamental immunology. Philadelphia: Lippincott-Raven; 1998. p. 1335-71.
12. Prevots D.R., Sutter R.W., Strebel P.M., Weibel R.E., Cochi S.L. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med. 148:1994;479-L 485
13. Cryz S.J. Jr. Post-marketing experience with live oral Ty21a vaccine. Lancet. 341:1993;49-50
14. ®. Ital J Trop Med. 6:2001;104-105
15. Tacket C.O., Cohen M.B., Wasserman S.S., et al. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. Infect Immun. 67:1999;6341-6345
16. Kaper J.B., Lockman H., Baldini M.M., Levine M.M. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature. 308:1984;655-658
17. Ketley J.M., Michalski J., Galen J., Levine M.M., Kaper J.B. Construction of genetically marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol Lett. 111:1993;15-21
18. Favre D., Struck M.M., Cryz S.J. Jr., Viret J.F. Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD 103-HgR. Vaccine. 14:1996;526-531
19. Cryz S, Glück R. Large-scale production of live attenuated bacterial and viral vaccines. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New generation vaccines. 2nd ed. New York: Marcel Dekker; 1997. p. 1153-63.
20. Cryz S.J. Jr., Levine M.M., Kaper J.B., Furer E., Althaus B. Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults. Vaccine. 8:1990;577-580
21. Kotloff K.L., Wasserman S.S., O'Donnell S., Losonsky G.A., Cryz S.J., Levine M.M. Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial. Infect Immun. 60:1992;4430-4432
22. Su-Arehawaratana P., Singharaj P., Taylor D.N., et al. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J Infect Dis. 165:1992;1042-1048
23. Suharyono, Simanjuntak C., Witham N., et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet. 340:1992;689-694
24. Tacket C.O., Losonsky G., Nataro J.P., et al. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis. 166:1992;837-841
25. Levine M.M., Kaper J.B., Herrington D., Ketley J., Losonsky G., Tacket C.O., Tall B., Cryz S. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet. 2:1988;467-470
26. Favre D., Cryz S.J. Jr., Viret J.F. Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139. Infect Immun. 64:1996;3565-3570
27. Waldor M.K., Mekalanos J.J. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science. 272:1996;1910-1914
28. Davis B.M., Waldor M.K. Filamentous phages linked to virulence of Vibrio cholerae. Curr Opin Microbiol. 6:2003;35-42
29. Faruque S.M., Albert M.J., Mekalanos J.J. Epidemiology, genetics and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev. 62:1998;1301-1314
30. Faruque S.M., Asadulghani, Kamruzzaman M., Nandi R.K., Ghosh A.N., Nair G.B., Mekalanos J.J., Sack D.A. RS1 element of Vibrio cholerae can propagate horizontally as a filamentous phage exploiting the morphogenesis genes of CTXphi. Infect Immun. 70:2002;163-170
31. Faruque S.M., Kamruzzaman M., Asadulghani, Sack D.A., Mekalanos J.J., Nair G.B. CTXphi-independent production of the RS1 satellite phage by Vibrio cholerae. Proc Natl Acad Sci U.S.A. 100:2003;1280-1285
32. Waldor M.K., Rubin E.J., Pearson G.D., Kimsey H., Mekalanos J.J. Regulation, replication, and integration functions of the Vibrio cholerae CTXphi are encoded by region RS2. Mol Microbiol. 24:1997;917-926
33. Trucksis M., Michalski J., Deng Y.K., Kaper J.B. The Vibrio cholerae genome contains two unique circular chromosomes. Proc Natl Acad Sci U.S.A. 95:1998;14464-14469
34. Davis B.M., Moyer K.E., Boyd E.F., Waldor M.K. CTX prophages in classical biotype Vibrio cholerae: functional phage genes but dysfunctional phage genomes. J Bacteriol. 182:2000;6992-6998
35. Basu A., Mukhopadhyay A.K., Garg P., et al. Diversity in the arrangement of the CTX prophages in classical strains of Vibrio cholerae O1. FEMS Microbiol Lett. 182:2000;35-40
36. Rubin E.J., Lin W., Mekalanos J.J., Waldor M.K. Replication and integration of a Vibrio cholerae cryptic plasmid linked to the CTX prophage. Mol Microbiol. 28:1998;1247-1254
37. Lin W., Fullner K.J., Clayton R., et al. Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U.S.A. 96:1999;1071-1076
38. Miller V.L., Taylor R.K., Mekalanos J.J. Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein. Cell. 48:1987;271-279
39. Bäck E., Svennerholm A.M., Holmgren J., Möllby R. Evaluation of a ganglioside immunosorbent assay for detection of E. coli heat-labile enterotoxin. J Clin Mircobiol. 10:1979;791-795
40. Alm R.A., Stroeher U.H., Manning P. Extracellular proteins of Vibrio cholerae: nucleotide sequence of the structural gene (hlyA) for the haemolysin of the haemolytic EL Tor strain O17 and the characterization of the hlyA mutation in the non-haemolytic classical strain 569B Mol Microbiol. 2:1988;481-488
41. Ketley J.M., Michalski J., Galen J., Levine M.M., Kaper J.B. Construction of genetically marked Vibrio cholerae O1 vaccine strains. Corrigendum: FEMS Microbiol Lett. 163:1998;269
42. Cryz S.J. Jr., Kaper J., Tacket C., Nataro J., Levine M.M. Vibrio cholerae CVD 103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects. Dev Biol Stand. 84:1995;235-244
43. Gerdes J.C., Romig W.R. Complete and defective bacteriophages of classical Vibrio cholerae: relationship to the Kappa type bacteriophages. J Virol. 15:1975;1231-1238
44. Guidolin A., Manning P. Genetics of Vibrio cholerae and its bacteriophages. Microbiol Rev. 51:1987;285-298
45. Cook W.L., Wachsmuth K., Johnson S.R., Birkness K.A., Samadi A.R. Persistence of plasmids, cholera toxin genes, and prophage DNA in classical Vibrio cholerae O1. Infect Immun. 45:1984;222-226
46. Newland J.W., Voll M.J., McNicol L.A. Serology and plasmid carriage in Vibrio cholerae. Can J Microbiol. 30:1984;1149-1156
47. Bartowsky E.J., Attridge S.R., Thomas C.J., Mayrhofer G., Manning P.A. Role of the plasmid P in attenuation of V. cholerae O1. Infect Immun. 58:1990;3129-3134
48. Kaper J.B., Morris J.G. Jr., Levine M.M. Cholera. Clin Microbiol Rev. 8:1995;48-86
49. Merrell D.S., Butler S.M., Qadri F., et al. Host-induced epidemic spread of the cholera bacterium. Nature. 417:2002;642-645
50. Mintz ED, Popovic T, Blake PA. Transmission of Vibrio cholerae O1. In: Wachsmuth IK, Blake PA, Olsvik O, editors. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology; 1994. p. 345-56.
51. Reidl J., Klose K.E. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol Rev. 26:2002;125-139
52. Watnick P.I., Kolter R. Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol. 34:1999;586-595
53. Watnick P., Kolter R. Biofilm, city of microbes. J Bacteriol. 182:2000;2675-2679
54. Ali A., Rashid M.H., Karaolis D.K. High-frequency rugose exopolysaccharide production by Vibrio cholerae. Appl Environ Microbiol. 68:2002;5773-5778
55. Colwell RR, Huq A. Vibrios in the environment: viable but nonculturable Vibrio cholerae. In: Wachsmuth IK, Blake PA, Olsvik O, editors. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology; 1994. p. 117-33.
56. Kell D.B., Kaprelyants A.S., Weichart D.H., Harwood C.R., Barer M.R. Viability and activity in readily culturable bacteria: a review and discussion of the practical issues. Antonie Van Leeuwenhoek. 73:1998;169-187
57. Freeman V.J. Further observations on the change to virulence of bacteriophage-infected avirulent strains of corynebacterium diptheriae. J Bacteriol. 63:1952;407-414
58. Freeman V.J. Studies of the virulence of bacteriophage-infected strains of corynebacterium diptheriae. J Bacteriol. 61:1951;675-688
59. Canchaya C., Fournous G., Chibani-Chennoufi S., Dillmann M.L., Brussow H. Phage as agents of lateral gene transfer. Curr Opin Microbiol. 6:2003;417-424
60. Wagner P.L., Waldor M.K. Bacteriophage control of bacterial virulence. Infect Immun. 70:2002;3985-3993
61. Faruque S.M., Asadulghani, Alim A.R., Albert M.J., Islam K.M., Mekalanos J.J. Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic Vibrio cholerae O1 and O139. Infect Immun. 66:1998;3752-3757
62. Faruque S.M., Rahman M.M., Hasan A.K., Nair G.B., Mekalanos J.J., Sack D.A. Diminished diarrheal response to Vibrio cholerae strains carrying the replicative form of the CTX(Phi) genome instead of CTX(Phi) lysogens in adult rabbits. Infect Immun. 69:2001;6084-6090
63. Pearson G.D., Woods A., Chiang S.L., Mekalanos J.J. CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc Natl Acad Sci U.S.A. 90:1993;3750-3754
64. Mekalanos J.J. Duplication and amplification of toxin genes in Vibrio cholerae. Cell. 35:1983;253-263
65. Davis B.M., Kimsey H.H., Chang W., Waldor M.K. The Vibrio cholerae O139 Calcutta bacteriophage CTXphi is infectious and encodes a novel repressor. J Bacteriol. 181:1999;6779-6787
66. Moyer K.E., Kimsey H.H., Waldor M.K. Evidence for a rolling-circle mechanism of phage DNA synthesis from both replicative and integrated forms of CTXphi. Mol Microbiol. 41:2001;311-323
67. Karaolis D.K., Johnson J.A., Bailey C.C., Boedeker E.C., Kaper J.B., Reeves P.R. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci U.S.A. 95:1998;3134-3139
68. Karaolis D.K., Somara S., Maneval D.R. Jr., Johnson J.A., Kaper J.B. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature. 399:1999;375-379
69. Faruque S.M., Zhu J., Asadulghani, Kamruzzaman M., Mekalanos J.J. Examination of diverse toxin-coregulated pilus-positive Vibrio cholerae strains fails to demonstrate evidence for Vibrio pathogenicity island phage. Infect Immun. 71:2003;2993-2999
70. Faruque S.M., Rahman M.M., Asadulghani, Nasirul Islam K.M., Mekalanos J.J. Lysogenic conversion of environmental Vibrio mimicus strains by CTXPhi. Infect Immun. 67:1999;5723-5729
71. Boyd E.F., Moyer K.E., Shi L., Waldor M.K. Infectious CTXPhi and the Vibrio pathogenicity island prophage in Vibrio mimicus: evidence for recent horizontal transfer between V. mimicus and V. cholerae. Infect Immun. 68:2000;1507-1513
72. Dalsgaard A., Serichantalergs O., Forslund A., Lin W., Mekalanos J., Mintz E., Shimada T., Wells J.G. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili. J Clin Microbiol. 39:2001;4086-4092
73. Miller J.F. Bacteriophage and the evolution of epidemic cholera. Infect Immun. 71:2003;2981-2982
74. Faruque S.M., Asadulghani, Rahman M.M., Waldor M.K., Sack D.A. Sunlight-induced propagation of the lysogenic phage encoding cholera toxin. Infect Immun. 68:2000;4795-4801
75. Glass RI, Black RE. The epidemiology of cholera. In: Barua D, Greenough III WB, editors. Cholera. New York: Plenum Medical Book Co.; 1992. p. 129-54.
76. Marvin D.A., Hohn B. Filamentous bacterial viruses. Bacteriol Rev. 33:1969;172-209
77. Model P, Russell M. Filamentous bacteriophages. In: Calendar R, editor. The bacteriophages. Vol. 2. New York: Plenum; 1988. p. 375-456.
78. Boyd E.F., Waldor M.K. Alternative mechanism of cholera toxin acquisition by Vibrio cholerae: generalized transduction of CTXPhi by bacteriophage CP-T1. Infect Immun. 67:1999;5898-5905
79. Kaper JB, Baldini MM. Genetics. In: Barua D, Greenough III WB, editors. Cholera. New York: Plenum Medical Book Co.; 1992. p. 69-94.
80. Kaper J.B., Michalski J., Ketley J.M., Levine M.M. Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR. Infect Immun. 62:1994;1480-1483
81. Bhaskaran K. Observations on the nature of genetic recombination in Vibrio cholerae. Indian J Med Res. 47:1959;253-260
82. Parker C., Romig W.R. Self-transfer and genetic recombination mediated by P, the sex factor of Vibrio cholerae. J Bacteriol. 112:1972;707-714
83. Spangler B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev. 56:1992;622-647
84. Mekalanos J.J., Swartz D.J., Pearson G.D.N., Harford N., Groyne F., de Wilde M. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature. 306:1983;551-557
85. Yamamoto T., Yokota T. Sequence of heat-labile enterotoxin of Escherichia coli pathogenic for humans. J Bacteriol. 155:1983;728-733
86. Yamamoto T., Tamura T., Yokota T. Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans. J Biol Chem. 259:1984;5037-5044
87. Gyles C.L., Palchaudhuri S., Maas W.K. Naturally occurring plasmids carrying genes for enterotoxin production and drug resistance. Science. 198:1977;198-199
88. Neill R.J., Ivins B.E., Holmes R.K. Synthesis and secretion of the plasmid-coded heat-labile enterotoxin of Escherichia coli in Vibrio cholerae. Science. 221:1983;289-291
89. Hirst T.R., Randall L.L., Hardy S.J. Cellular location of heat-labile enterotoxin in Escherichia coli. J Bacteriol. 157:1984;637-642
90. Neill R.J., Twiddy E.M., Holmes R.K. Synthesis of plasmid-coded heat-labile enterotoxin in wild-type and hypertoxinogenic strains of Escherichia coli and in other genera of Enterobacteriaceae. Infect Immun. 41:1983;1056-1061
91. Kado C.I., Liu S.T. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol. 145:1981;1365-1373
92. Rahal K., Gerbaud G., Bouanchaud D.H. Stability of R plasmids belonging to different incompatibility groups in Vibrio cholerae "Eltor" Ann Microbiol (Paris). 129:1978;409-414
93. Sack D.A., Sack R.B. Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun. 11:1975;334-336
94. 2+. Can J Microbiol. 34:1988;1090-1095
95. Fitzgerald WF. Distribution of mercury in natural waters. In: Nriagu JO, editor. The biogeochemistry of mercury in the environment. New York: Elsevier; 1979. p. 161-74.
96. Liebert C.A., Barkay T., Turner R.R. Acclimation of aquatic microbial communities to Hg(II) and CH3Hg+ in polluted freshwater ponds. Microb Ecol. 21:1991;139-149